SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055727
Filing Date
2024-05-08
Accepted
2024-05-08 16:21:34
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sana-20240331.htm   iXBRL 10-Q 2338777
2 EX-10.1 sana-ex10_1.htm EX-10.1 42368
3 EX-31.1 sana-ex31_1.htm EX-31.1 16008
4 EX-31.2 sana-ex31_2.htm EX-31.2 14800
5 EX-32.1 sana-ex32_1.htm EX-32.1 8486
6 EX-32.2 sana-ex32_2.htm EX-32.2 8249
7 GRAPHIC img112676973_0.jpg GRAPHIC 392794
  Complete submission text file 0000950170-24-055727.txt   10133928

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20240331.xsd EX-101.SCH 1324812
83 EXTRACTED XBRL INSTANCE DOCUMENT sana-20240331_htm.xml XML 1585248
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 24926525
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)